This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

Researcher details his personal battle with cancer

cancer
Cancer cell during cell division. Credit: National Institutes of Health

On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new brief report in Oncoscience titled "My battle with cancer. Part 1."

Dr. Blagosklonny writes, "In January 2023, diagnosed with numerous metastases of in my brain, I felt that I must accomplish a mission. If everything happens for a reason, my cancer, in particular, I must find out how metastatic cancer can be treated with curative intent. This is my mission now, and the reason I was ever born.

"In January 2023, I understood the meaning of life, of my life. I was born to write this article. In this article, I argue that monotherapy with targeted drugs, even when used in sequence, cannot cure metastatic cancer. However, preemptive combinations of targeted drugs may, in theory, cure incurable cancer. Also, I share insights on various topics, including rapamycin, an anti-aging that can delay but not prevent , through my personal journey."

More information: Mikhail V. Blagosklonny, My battle with cancer. Part 1, Oncoscience (2024). DOI: 10.18632/oncoscience.593

Provided by Impact Journals LLC
Citation: Researcher details his personal battle with cancer (2024, January 22) retrieved 3 May 2024 from https://medicalxpress.com/news/2024-01-personal-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Research perspective: Cancer prevention with rapamycin

 shares

Feedback to editors